News
Analysts Cut Price Targets For Praxis Precision After Trial Setback For Essential Tremor Candidate Praxis Precision Medicines' ulixacaltamide study for essential tremor faces setback as IDMC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback